Megan Guerre1, Colin Boehnlein1, Roya Sohaey2, Casey A Seideman3. 1. School of Medicine, Oregon Health & Science University, Portland, OR, USA. 2. Department of Diagnostic Radiology, Oregon Health & Science University, Portland, OR, USA. 3. Department of Urology, OHSU Doernbecher Children's Hospital, Oregon Health & Science University, 700 S.W. Campus Drive, Portland, OR, 97239, USA. Seideman@ohsu.edu.
Abstract
PURPOSE OF REVIEW: Our goal was to summarize current literature related to imaging of intra-abdominal genitourinary tumors diagnosed in the prenatal or neonatal period. Our specific interests included modalities used, diagnoses made, changing incidence of tumor detection, and proposed future uses of these imaging modalities. RECENT FINDINGS: Fetal and neonatal MRI have been used as an adjunct to ultrasound for better characterization and assessment of congenital mesoblastic nephroma, juvenile granulosa cell tumor, and other tumors. Despite recent literature describing fetal and neonatal MRI, it is not yet possible to determine whether its use is changing the incidence of tumor detection. Improvements in imaging technology, specifically the use of fetal MRI, have allowed for earlier identification of genitourinary masses with improved capability for diagnosis, surveillance, surgical planning, and sometimes prenatal treatment of the malignancy and related diagnoses, with a goal of preventing pregnancy and delivery complications.
PURPOSE OF REVIEW: Our goal was to summarize current literature related to imaging of intra-abdominal genitourinary tumors diagnosed in the prenatal or neonatal period. Our specific interests included modalities used, diagnoses made, changing incidence of tumor detection, and proposed future uses of these imaging modalities. RECENT FINDINGS: Fetal and neonatal MRI have been used as an adjunct to ultrasound for better characterization and assessment of congenital mesoblastic nephroma, juvenile granulosa cell tumor, and other tumors. Despite recent literature describing fetal and neonatal MRI, it is not yet possible to determine whether its use is changing the incidence of tumor detection. Improvements in imaging technology, specifically the use of fetal MRI, have allowed for earlier identification of genitourinary masses with improved capability for diagnosis, surveillance, surgical planning, and sometimes prenatal treatment of the malignancy and related diagnoses, with a goal of preventing pregnancy and delivery complications.
Authors: R A Kubik-Huch; T A Huisman; J Wisser; N Gottstein-Aalame; J F Debatin; B Seifert; M E Ladd; T Stallmach; B Marincek Journal: AJR Am J Roentgenol Date: 2000-06 Impact factor: 3.959
Authors: M Chad Wallis; Armando J Lorenzo; Walid A Farhat; Darius J Bägli; Antoine E Khoury; Joao L Pippi Salle Journal: J Urol Date: 2008-05-21 Impact factor: 7.450
Authors: Sara Savelli; Marco Di Maurizio; Anna Perrone; Jacopo Tesei; Antonella Francioso; Marco Angeletti; Laura La Barbera; Laura Ballesio; Carlo de Felice; Lucio Maria Porfiri; Lucia Manganaro Journal: Prenat Diagn Date: 2007-12 Impact factor: 3.050